Daily Newsletter
Help us improve your experience, delivering more of what you want
TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, announced today that it has published its...
First Name
Last Name
Email address:
Add this web page on your home screen for quick and easy access when you’re on the go.